Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply

NEXT STORY
Aileron Therapeutics Presents Initial Findings from Ongoing Healthy Volunteer Study of ALRN-6924 at ISEH 50th Annual Scientific Meeting
PREV STORY
Health Canada approval of low-dose colchicine for cardiovascular disease based on the COLCOT study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Client Outlook’s eUnity™ Selected as the Enterprise Image Viewing Platform for Tampa General Hospital

WATERLOO, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA ...

author_avatar
NASDAQ Market News

Selecta Biosciences to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News

G1 Therapeutics to Provide Third Quarter 2018 Corporate and Financial Update on November 7, 2018

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: ...

author_avatar
NASDAQ Market News